Bilgehan Aygen, et al. “Immunosuppressive Therapy and the Risk of Hepatitis B Reactivation: Consensus Report”. Turkish Journal of Gastroenterology, vol. 29, no. 3, July 2019, pp. 259-6, https://tjg.avesjournals.com/index.php/tjg/article/view/3536.